- Issuer ticker
-
PCSA
- Reported as of
-
16 Aug 2022
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
23 Aug 2022, 16:30:49 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Key filing fact
David Young filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 23 Aug 2022.
Key facts
- This page summarizes David Young's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Aug 2022, 16:30.
Change
- Previous filing in this sequence was filed on 09 Aug 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCSA
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -9,250
- Change %
- -2.4%
- Price
-
$0.000000
- Shares after
- 377,784
- Date
- 16 Aug 2022
- Ownership
- Direct
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 573,568
- Date
- 16 Aug 2022
- Ownership
- By Young-Plaisance Revocable Trust
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 694,591
- Date
- 16 Aug 2022
- Ownership
- By Family Entities
PCSA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 37,504
- Date
- 16 Aug 2022
- Ownership
- By CorLyst, LLC
* marks a reported price that did not pass the local price check.